Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C30H30N6O3S |
| Molecular Weight | 554.663 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=C(CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4)C(=O)N(CC5=C(C=CS5)C(=O)OC)C(C)=N1
InChI
InChIKey=QVFVAKQHELFATN-UHFFFAOYSA-N
InChI=1S/C30H30N6O3S/c1-4-5-10-26-25(29(37)36(19(2)31-26)18-27-24(15-16-40-27)30(38)39-3)17-20-11-13-21(14-12-20)22-8-6-7-9-23(22)28-32-34-35-33-28/h6-9,11-16H,4-5,10,17-18H2,1-3H3,(H,32,33,34,35)
| Molecular Formula | C30H30N6O3S |
| Molecular Weight | 554.663 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dual action molecules: bioassays of combined novel antioxidants and angiotensin II receptor antagonists. | 2012-11-15 |
|
| Tandem free-radical addition/substitution chemistry and its application to the preparation of novel AT1 receptor antagonists. | 2011-01-21 |
|
| Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist. | 1995-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:42 GMT 2025
by
admin
on
Mon Mar 31 18:22:42 GMT 2025
|
| Record UNII |
8UAL5421CL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66930
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C527223
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
148564-47-0
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
100000080633
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL429847
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
8UAL5421CL
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
7557
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
DTXSID70164007
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
C66152
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
SUB08963MIG
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY | |||
|
3047757
Created by
admin on Mon Mar 31 18:22:42 GMT 2025 , Edited by admin on Mon Mar 31 18:22:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|